Heart attack patients monitored for new AFib risk

NCT ID NCT05511649

Completed Knowledge-focused Sponsor: Shanghai 10th People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tracked 832 heart attack patients in China who developed new-onset atrial fibrillation during their hospital stay. Researchers used continuous heart monitoring to see how the amount of AFib affected risks like death, another heart attack, or heart failure. The goal is to better understand which patients need closer follow-up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict risks and tailor care for heart attack patients who develop new atrial fibrillation.
What could go wrong: This is an observational study, not a treatment trial, so it cannot directly improve outcomes. Results may not apply outside China or to other hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction atrial fibrillation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYOCARDIAL INFARCTION NEW ONSET ATRIAL FIBRILLATION

Contacts and locations

Locations

KaiFeng Central Hospital

Kaifeng, Henan, China
Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, 200072, China
The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.